Next-Generation Hemostatic System
Legal Citation
Summary of the Inventive Concept
A futuristic hemostatic system that leverages cutting-edge technologies to revolutionize bleeding control, offering unparalleled efficacy, convenience, and safety.
Background and Problem Solved
The original patent's hemostatic composition, comprising an anion exchanger and a calcium salt, has limitations in terms of application, delivery, and biocompatibility. The new inventive concept addresses these limitations by integrating advanced technologies to create a more efficient, user-friendly, and adaptable system for inducing hemostasis.
Detailed Description of the Inventive Concept
The next-generation hemostatic system consists of a portable device housing a hemostatic composition, a sensor for detecting bleeding, and a nanocarrier-based delivery system. The system can be worn as a wearable device, featuring a micro-needling system for delivering the composition to the site of bleeding. Alternatively, the composition can be applied through an electrostatically-charged spray nozzle. The hemostatic composition itself comprises an anion exchanger, a calcium salt, and a bio-absorbable polymer matrix, designed to dissolve over time, eliminating the need for removal.
Novelty and Inventive Step
The new claims introduce a paradigm shift in hemostatic technology by integrating advanced delivery systems, sensors, and wearable devices, which are not obvious extensions of the original patent's composition-based approach.
Alternative Embodiments and Variations
Other embodiments of the inventive concept could include implantable devices, injectable compositions, or even bio-printed matrices. Variations may involve different types of sensors, delivery mechanisms, or bio-absorbable materials.
Potential Commercial Applications and Market
The next-generation hemostatic system has vast commercial potential in the medical, military, and emergency response industries, offering a game-changing solution for bleeding control and wound management.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically hemostatic compositions and medical device technologies focused on wound treatment and bleeding control
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with expertise in materials science, polymer chemistry, and advanced drug delivery systems, holding at least a master's degree with 3-5 years of specialized experience in hemostatic technologies
Obviousness Rationale
A PHOSITA would recognize that the published technical disclosure represents predictable variations of the source patent's core hemostatic composition technology. The fundamental chemical principles of anion exchangers and calcium salts remain consistent, while the delivery mechanisms represent logical extensions of known medical device design principles. The proposed variations demonstrate incremental improvements that would be obvious to a skilled practitioner seeking to optimize hemostatic interventions.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,564 |
|---|---|
| Title | Hemostatic composition comprising an anion exchanger and a calcium salt |
| Assignee(s) | Omrix Biopharmaceuticals Ltd. |